NEW YORK, April 1, 2013 /PRNewswire/ --
The Standard & Poor's 500 hit a new record Thursday morning; three weeks after the Dow Jones beat its 2007 record. EBay executives said the Company aims to handle $110 billion of sales volume in its marketplace in 2015 by expanding globally.
Whether bull or bear The Stock Freak has got you covered! Sign up to receive our free newsletters and stay up to date with stocks on the run.http://www.TheStockFreak.com
Dollar General Corporation (NYSE: DG) - Dollar General Corp. had one of the biggest volume advances on the NYSE on Thursday, trading nearly 31 million shares. The Company announced Wednesday the pricing of an underwritten secondary public offering of 30 million common shares at a price to the public of $50.75 per share.
Many mid or large cap stocks once started off asPenny stocks!
BlackBerry (Nasdaq: BBRY) - BlackBerry traded over 105 million shares on Thursday after reporting mixed results that included a surprise profit in Q4.
Southcross Energy Partners, L.P. (NYSE: SXE) - Shares of SXE sank to a new 52-week low of $20.15 on Thursday after reporting fourth quarter and full year 2012 financial and operating results in the early morning.
Penny stocks can deliver sky-rocketing returns and are a popular choice among many investors in the market because of how much lower they trade than big cap companies.
Repros Therapeutics Inc. (Nasdaq: RPRX) - Repros Therapeutics was one of the biggest advancers on the Nasdaq composite on Thursday seeing gains as high as 79% in intra-day trading. The Company's experimental drug to treat low levels of testosterone met the main goals of a key study.
Gilead Sciences Inc. (Nasdaq: GILD) - GILD hit a new all-time high of $49.48 on Thursday after an ISI Group analyst said sales estimates must go "way way up" on its experimental hepatitis C therapy.
To find similar research reports that are available for free follow the link below and sign up at http://www.TheStockFreak.com
Disclosure: TheStockFreak.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.